West Pharmaceutical Services Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2024
Total Assets: $3.64B
Liabilities Breakdown FY2024
Total Liabilities: $961.1M
Asset Breakdown
Total Assets: $3.64B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $484.6M | 13.3% |
| Accounts Receivable | $552.5M | 15.2% |
| Inventory | $377.0M | 10.3% |
| Property, Plant & Equipment | $1.58B | 43.4% |
| Goodwill | $106.0M | 2.9% |
| Intangible Assets | $10.8M | 0.3% |
| Other Assets | $530.9M | 14.6% |
Liabilities Breakdown
Total Liabilities: $961.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $239.3M | 24.9% |
| Long-Term Debt | $202.6M | 21.1% |
| Other Liabilities | $519.2M | 54.0% |